Effect of Asteracantha longifolia Nees. against galactosamine induced liver dysfunction in rat

Toxicology International

Volumn 14, Issue 1, 2007, Pages 7-13

  Shailajan, Sunita ^a   Chandra, Naresh ^a   Sane, R T ^a   Menon, Sasikumar ^a  

^a RAMNARAIN RUIA COLLEGE   (India)

Author keywords

Asteracantha longifolia; Galactosamine; Hepatoprotection; Liver function test

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; ASTERACANTHA LONGIFOLIA EXTRACT; BILIRUBIN; CHOLESTEROL; GALACTOSAMINE; GAMMA GLUTAMYLTRANSFERASE; GLYCOGEN; PLANT EXTRACT; SILYMARIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ACANTHACEAE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS SOLUTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASTERACANTHA LONGIFOLIA; BILIRUBIN BLOOD LEVEL; BLOOD ANALYSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFICACY; DRUG ISOLATION; DRUG MECHANISM; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HISTOPATHOLOGY; LIVER DYSFUNCTION; LIVER FUNCTION TEST; LIVER PROTECTION; MALE; NONHUMAN; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

ASTERACANTHA LONGIFOLIA; RATTUS;

EID: 34547980990     PISSN: 09716580     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Balachandran, I and Sivarajan, VV (1994): Ayurvedic drugs and their plant sources, in: Kokilaksah: Oxford and IBH Publishing Company Pvt. Ltd. (Eds: 1) New Delhi, 249-250.
2. Gogte V M (2000): Ayurvedic pharmacology therapeutic uses of medicinal plants, in: Dravyagunavignyan. The Academic Team of Bharatiya Vidya Bhavan's Swami Prakashananda Ayurvedic Research Centre (SPARC). Bharatiya Vidya Bhavan, Mumbai 2000. 592-593.
3. Thakur, CB, Dixit, VP and Saraf, S (1991): Hepatoprotective activity of Asteracantha longifoia Nees., Indian drugs, 28(9), 400-402.
4. Singh, A. and Handa, SS (1995): Hepatoprotective activity of Apium graveolens and Hygrophila auriculata against paracetamol and thioacetamide intoxication in rats. J. Ethanopharmacol., 49: 119-126.
5. Shah MC, Patel, PH, Phadke, MM, Menon, S, and Sane, RT (1999): Hepatoprotective action of extracts of Phyllanthus debilis in various solvents. J Biores., 2: 11-26
6. 4 induced rat liver dysfunction. Indian Drugs. 39(6): 333-337.
7. 4 induced liver dysfunction in rat. Ind. J. Exp. Biol., 43: 68-75.
8. MacDonald, RJ Gandolfi, JA and Sipes, GI (1985): Structural requirements for cytoprotective agents in galactosamine induced hepatic necrosis. Toxicol. Appl. Pharmacol., 81: 17-24.
9. MacDonald, RJ Thayer, KJ and Carol, WJ (1987): Inhibition of galactosamine cytotoxicity in an in vivo/vitro hepatocellular toxicity model. Toxicol. Appl. Pharmacol., 89: 269-277.
10. Munro, HN and Fleck, A (1967): Determination of Nucleic acids, in: Methods of biochemical analysis, Vol.XIV, (Eds: Glick, D) Interscience, New York. 113-176.
11. Ceriotti, G (1955): Determination of nucleic acids in animal tissues. J. Biol. Chem., 214: 60-70.
12. Keppler, D Lesch, R Reutter, W and Decker, K (1968): Experimental hepatitis induced by D- galactosamine. Experimental and Molecular Pathology, 9: 279-290.
13. Medline, A Schaffner, F and Popper, H (1970): Ultrastructural features in galactosamine induced hepatitis. Experimental and Molecular Pathology, 12: 201-211.
14. Keppler, D and Decker, K (1969): Studies on the mechanism of galactosamine hepatitis: Accumulation of galactosamine-1-phosphate and its inhibition of UDP-glucose pyrophosphorylase. European J. Biochem., 10: 219-225.
15. Koff, RS Gordon, G and Sabesin, SM (1971): D-Galactosamine Hepatotoxicity - I, Hepatocellular injury and fatty liver following a single dose. Proc. Soc. Expt. Biol. Med., 137: 696-701.
16. Koff, RS Fitts, JJ and Sabesin, SM (1971): D-Galactosamine Hepatotoxicity - II, Mechanism of fatty liver production. Proc. Soc. Expt. Biol. Med., 138: 89-92.
17. Koff, RS Lorna, JD Gordon, G and Sabesin, SM (1973): D-Galactosamine Hepatotoxicity - III, Normative Smooth Endoplasmic Reticulum and Modification by Phenoburbital, Experimental and Molecular Pathology, 19: 168.
18. Koff, RS and Sabesin, SM (1976): D-Galactosamine Hepatotoxicity - IV, Further studies of the pathogenesis of fatty liver. Experimental and Molecular Pathology 24, 424.
19. Bloom, and Fawcett (1994): A text book of histology (Edn 12th) Chapman and Hall, New York - London. 652.
20. Nowak, M et al. (2000): LPS-induced liver injury in D-galctosamine-sensitized mice requires secreted TNF-μ and the TNF-p55 receptor. Am. J. Physiol. Regul. Integr. Comp. Physiol., 278: R1202-R1209.